Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382538 · ClinicalTrials.gov registry record · NA
Mifepristone and Mid-Trimester Termination of Pregnancy
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT00382538 is a NA study that has completed, run by Boston University. The registered enrollment target is 64 participants.
The verdict
NCT00382538, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
Mid-second trimester medical terminations of pregnancy require admission to the hospital for the length of time it takes a woman to abort. The current protocol at BMC uses intra-amniotic digoxin injection the day prior to admission. The following day, the woman is admitted and given sequential doses of misoprostol until delivery occurs. The average length of time between the first dose of misoprostol and delivery is 12 hours, requiring most women to stay overnight. This is a randomized, placebo-controlled, double-blinded study designed to determine whether adding mifepristone significantly reduces the induction interval time (time between starting the first misoprostol and delivery) required for a second trimester termination.
Interventions
- DRUG Addition of mifepristone 200 mg 24 hours before induction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2005-03 |
| Est. Completion | 2006-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00382538
The ClinicalTrials.gov registry entry for NCT00382538 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Addition of mifepristone 200 mg 24 hours before induction is the first listed.
NCT00382538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00382538 about?
NCT00382538 is a clinical study titled "Mifepristone and Mid-Trimester Termination of Pregnancy". Mid-second trimester medical terminations of pregnancy require admission to the hospital for the length of time it takes a woman to abort. The current protocol at BMC uses intra-amniotic digoxin injection the day prior to admission. The following day, the woman is admitted and given sequential doses...
What is the current status of trial NCT00382538?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2005-03. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00382538?
The interventions under investigation include: Addition of mifepristone 200 mg 24 hours before induction (DRUG).
Who is sponsoring clinical trial NCT00382538?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.